Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit p…
Medical - Healthcare Plans
US, Louisville [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | -82.67 | 36.63 | -211.42 | |
| Graham Fair Price | 17.99 | 135.55 | 114.89 | |
| PEG | -61.59 | -0.06 | 0.16 | |
| Price/Book | -23.54 | 2.64 | 3.45 | |
| Price/Cash Flow | 2186.55 | 172.84 | -7.56 | |
| Prices/Earnings | -44.63 | 14.34 | -25.91 | |
| Price/Sales | -32.23 | 1.44 | 2.12 | |
| Price/FCF | 2186.55 | 172.84 | -7.56 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | 4.90 | 0.90 | 0.86 | |
| Operating Margin | 258.62 | 0.04 | -0.01 | |
| ROA | 28.22 | 0.01 | -0.01 | |
| ROE | -0.03 | 0.05 | 38.09 | |
| ROIC | < 0.005 | 0.03 | 231.06 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | 0.08 | 0.02 | 211.97 | |
| Dividends QOQ | 0.03 | < 0.005 | -77.32 | |
| EBIT QOQ | -1.26 | 5.01 | 299.32 | |
| EPS QOQ | -1.66 | 2.39 | 44.15 | |
| FCF QOQ | -8.29 | 1.03 | -87.53 | |
| Revenue QOQ | < 0.005 | 0.12 | 7962.46 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Balanced
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | -549.24 | -784.97 | -42.92 | |
| Days Sales Outstanding (DSO) | 6.92 | 11.93 | 72.36 | |
| Inventory Turnover | -0.16 | -0.11 | 30.03 | |
| Debt/Capitalization | 0.42 | 0.45 | 6.95 | |
| Quick Ratio | 1.24 | 1.35 | 8.89 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Positive
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 132.79 | 133.33 | 0.40 | |
| Cash | 174.10 | 186.87 | 7.34 | |
| Capex | -2.31 | -1.46 | 36.69 | |
| Free Cash Flow | -60.57 | 2.03 | -96.64 | |
| Revenue | 216.09 | 244.76 | 13.27 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Positive
Fundamentals
Financial Health
06 - Financial Health ·
Weak